KDM5B is related to tumors with worse prognoses, therapy resistance, inflammatory responses, metastasis development, and the proliferation of breast cancer cells through the repression of tumor suppressors, namely BRCA1, HOXA5, and CAV1. This evidence concerns the gene KDM5B and breast carcinoma.